Rare Patient Voice holds a clear lead for connecting researchers directly with rare disease patients and caregivers through advocacy networks. MedPanel is the usual answer when buyers specifically seek recruitment agencies focused on rare, ultra-rare, and pediatric populations through physician partnerships.
Genome MedicalChatGPT Search58%Google AI Mode4%ChatGPT SearchGoogle AI Mode
IQVIAChatGPT Search21%Google AI Mode29%ChatGPT SearchGoogle AI Mode
Questions and answers
I need a patient recruitment agency that focuses on rare disease populations.
Google AI Mode· Oct 13, 2026
When recruiting for rare disease populations, standard broad-reach recruitment tactics rarely work. You need specialists who leverage advocacy partnerships, deep genetic/data profiling, and targeted digital communities.
Top patient recruitment agencies and platforms with strong capabilities and distinct models for rare disease trials include:
If you'd like to narrow this down, tell me a bit more about your trial:
I can help you pinpoint which agency aligns best with your protocol.
If you’re looking for a patient recruitment agency that specializes in rare disease populations, I’d prioritize firms with rare-disease patient registries, relationships with advocacy groups, access to hard-to-reach patient communities, and experience recruiting for clinical trials.
One important distinction: some agencies specialize in finding and enrolling patients for clinical trials, while others focus on patient engagement, site recruitment, or identifying eligible participants for observational studies. The best fit depends on your study design and the specific rare disease population.
My top recommendations
These are the strongest starting points I found for a sponsor, biotech, CRO, or research team seeking rare-disease participants.
1. Rare Patient Voice
(Strong starting point)
Specializes in connecting researchers with rare-disease patients and caregivers for clinical research. Its network spans more than 1,500 diseases and conditions, with recruitment through advocacy organizations, support groups, and digital outreach.
Best for: Reaching established rare-disease communities for clinical trials or research studies.
Focuses on rare and ultra-rare disease recruitment, including pediatric populations. Its approach combines advocacy partnerships, patient prescreening, and hands-on support for families.
Best for: Difficult-to-enroll trials, small patient populations, and studies that need active recruitment support.
Offers rare-disease recruitment with cross-border logistics, advocacy partnerships, patient prescreening, and support for travel or in-home visits where appropriate. Its stated experience includes myasthenia gravis and small fiber neuropathy.
Best for: International studies and populations spread across multiple countries or specialist centers.
Provides patient recruitment as part of a broader clinical development offering, using researcher networks, advocacy relationships, global reach, and biomarker-driven screening when appropriate. It also describes experience enrolling patients in a rare-disease natural history study.
Best for: Biotech and pharmaceutical sponsors seeking recruitment integrated with broader clinical trial services.
The National Organization for Rare Disorders (NORD) operates the IAMRARE research platform, which supports patient-powered natural history studies and disease registries. It may be particularly useful if you need registry-based recruitment or a partnership with established rare-disease communities rather than a conventional recruitment vendor.
How I would choose
Your priority
Start with
Access to a broad rare-disease patient network
Rare Patient Voice
Ultra-rare or pediatric clinical trial enrollment
Leapcure
Multinational recruitment and patient logistics
Patiro
Recruitment integrated with CRO services
Precision for Medicine
Advocacy-led engagement and recruitment strategy
These are initial matches based on publicly described services, not independently verified performance rankings. Before selecting a vendor, ask for disease-specific enrollment results, verified patient reach, geographic coverage, screening-to-enrollment conversion rates, and references from comparable studies.
Let me narrow this down to the best fit
Which rare-disease population are you trying to recruit? If you share the disease or therapeutic area, I can identify the agencies most likely to have relevant patient access and experience with that specific population. It would also help to know whether this is for a clinical trial, a natural history study, or market research.
Genome Medical — Especially interesting for genetic rare diseases
Provides trial matching/recruitment plus genetic counseling and testing.
Its patient population is enriched for rare genetic conditions, and it can identify additional potential candidates within patients' families.
This could be particularly valuable if genetic confirmation is part of your inclusion criteria.
subrosa Health & Capital — Worth considering for extremely hard-to-find populations
Focuses specifically on identifying rare-disease patients using genetically confirmed clinical data.
Reports more than 58,000 rare-disease patients recruited, 57 international patient-identification/recruitment programs, and studies in 48 countries.
If I were selecting a vendor
For a Phase II/III rare-disease trial where enrollment is the bottleneck, I'd initially speak with Patiro, Precision for Medicine, and Rare Patient Voice.
If the disease is ultra-rare or genetically defined, I'd add Genome Medical and subrosa to the RFP.
One important distinction: patient recruitment isn't the same as patient identification. Some vendors are primarily digital/advocacy recruiters, while others can actually identify likely eligible patients from EHR/genetic/clinical data. For a very small patient population, that distinction can have a huge effect on enrollment.
If you tell me the rare disease, country/region, trial phase, and approximate enrollment target, I can narrow this to 3–5 vendors that are specifically suited to your trial and compare their capabilities, pricing models, and evidence of past recruitment success.
Finding patients for rare disease clinical trials requires specialized strategies, deep data access, and close collaboration with patient advocacy groups, rather than broad public advertising. Several top-tier service providers and Contract Research Organizations (CROs) specialize or excel in rare disease patient recruitment:[](https://clinicalenrollment.com/resources/patient-recruitment-companies-compared/)
IQVIA : A market leader that combines massive healthcare data assets, AI-driven rare disease detection algorithms, and extensive rare disease registry platforms. They track millions of documented rare disease patients globally and feature dedicated pediatric and rare disease centers of excellence.[](https://www.patiro.com/insights/top-10-best-rare-disease-clinical-trial-recruitment-companies)
: A specialized CRO that explicitly positions its operations around rare disease and orphan drug clinical trials, offering targeted recruitment strategies and regulatory navigation for small-to-large biopharma.[]()
Syneos Health : Known for its integrated recruitment and retention solutions, including a dedicated Rare Disease Consortium that collaborates across specialties to execute non-interventional studies, registries, and targeted patient-centric enrollment campaigns.
Patiro : Frequently recognized for dedicated patient recruitment and site support infrastructure tailored to challenging or niche therapeutic enrollments.
To help narrow down the best fit, could you share:
What specific rare disease or therapeutic area the trial is targeting?
What geographic regions you need to recruit patients from?
